Skip to main content

Table 1 Demographic and clinical characteristic of the study population

From: A comparison between different anti-retroviral therapy regimes on soluble inflammation markers: a pilot study

 

Group 1

Group 2

Group 3

Age (years)

49.7 (45.9–57.0)

52.9 (47.4–57.1)

53.7 (45.3–61.6)

CD4 + 

857 (669–1045)

727 (527–926)

701 (545–857)

Sex (female, %)

44.4

50.0

33.3

Smoking status (smokers, %)

55.6

50.0

50.0

Disease Duration (years)

16.0 (11.3–20.7)

15.5 (11.6–19.5)

10.4 (8.7–12.2)

Triglycerides (mg/dL)

150 (83–217)

134 (91–176)

126 (103–149)

Total cholesterol (mg/dL)

220 (193–247)

210 (185–235)

229 (210–248)

  1. Continue variables are expressed as mean (95% Confidence Interval). Categorical variables are expressed as percentage